Highmark Health’s VITAL Innovation Platform testing benefits of innovations from Sensible Medical related to measurement of lung fluid in patients with congestive heart failure


The VITAL plat­form is testing Sensible Medical’s ReDS Fluid Monitoring System through July of 2019 among 100 patients with recent conges­tive heart failure admis­sions who are being discharged from an Allegheny Health Network hospital to a skilled nursing facility. The ReDS system features a nonin­va­sive vest” that within 90 seconds can supple­ment the stetho­scope by using radio frequency tech­nology to provide an objec­tive measure of conges­tion in the lungs related to pulmonary edema. If threshold levels of fluids exist, patients would remain in the nursing facility for further treat­ment until discharge levels are met. Using the ReDS system has the poten­tial to reduce prema­ture patient discharges that can result in emer­gency rooms episodes and costly hospital read­mis­sions.

Sensible Medical’s ReDSTM Fluid Monitoring Device System


Spearheading the Sensible Medical ReDS test is lead inves­ti­gator Dr. Srinivas Murali of Allegheny Health Network’s Allegheny General Hospital in Pittsburgh.